Veracyte Announces First Quarter 2024 Financial Results
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Business Wire
Grew total revenue to $96.8 million, an increase of 17%Grew testing revenue by 25%Conference call and webcast today at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the first quarter ended March 31, 2024.“We had a strong start to 2024, driven by robust growth from our market-leading Decipher Prostate and Afirma tests. We executed upon our strategies to further penetrate these markets by expanding our clinical evidence, and, for Decipher, securing enhanced status in guidelines while also achieving a key commercial reimbursement milestone,” said Marc Stapley, Veracyte’s chief executive officer. “We also expanded our capabilities into minimal residual disease (MRD) testing by completing our acquisition of C2i Genomics and initiating development of our first test using their novel, whole-genome approach.”Key Business HighlightsIncreased first quarter total revenue by 17% to $96.8 million, compared to the f
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Veracyte to Participate in Upcoming Investor ConferencesBusiness Wire
- Wall Street Analysts Believe Veracyte (VCYT) Could Rally 39.59%: Here's is How to Trade [Yahoo! Finance]Yahoo! Finance
- Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount? [Yahoo! Finance]Yahoo! Finance
- Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View [Yahoo! Finance]Yahoo! Finance
VCYT
Earnings
- 5/7/24 - Beat
VCYT
Sec Filings
- 5/8/24 - Form 10-Q
- 5/7/24 - Form 8-K
- 4/25/24 - Form ARS
- VCYT's page on the SEC website